Abstract

Immunotherapy use is increasing in frequency among oncology patients as a single treatment or combined with chemotherapy. Immunotherapy related adverse events (IrAE) have unique presentations that are often overlooked or misdiagnosed. This IRB approved study sought to evaluate the effectiveness of microteaching on ED nurses and physicians' identification of IrAEs and timely initiation of definitive therapy.

Author Details

Elizabeth J. Winokur, PHD, RN, CEN; Enza Esposito Nguyen, DNP, RN, ANP-BC, AOCNP; Johnny D. Nguyen, BS

Sigma Membership

Non-member

Type

Poster

Format Type

Text-based Document

Study Design/Type

Descriptive/Correlational

Research Approach

N/A

Keywords:

Immunotherapy Related Adverse Events, Microteaching, Research

Conference Name

Emergency Nursing 2019

Conference Host

Emergency Nurses Association

Conference Location

Austin, Texas, USA

Conference Year

2019

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Review Type

Abstract Review Only: Reviewed by Event Host

Acquisition

Proxy-submission

Poster

Additional Files

Abstract.pdf (103 kB)

Share

COinS
 

Look for zebras: Identification of immunotherapy patients in the emergency department

Austin, Texas, USA

Immunotherapy use is increasing in frequency among oncology patients as a single treatment or combined with chemotherapy. Immunotherapy related adverse events (IrAE) have unique presentations that are often overlooked or misdiagnosed. This IRB approved study sought to evaluate the effectiveness of microteaching on ED nurses and physicians' identification of IrAEs and timely initiation of definitive therapy.